About this trial
Idiopathic scoliosis is the most common spinal deformity in children and adolescents with an estimated prevalence of 3%. About one tenth of the children with scoliosis develop a deformity that requires treatment with brace or surgery with the current treatment protocol. When brace treatment for scoliosis is indicated, standard treatment consists of bracing 20 hours or more per day. Outcomes of brace treatment depend to a large extent on wearing time and since many adolescents feel uncomfortable in the brace, it is of importance to combine efficacy and comfortability of the brace.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Cobb 25-40 degrees
Skeletally immature, Sanders score of 6 or less and Risser 2 or less.
Menarche status maximum one year in females
Aged 9-17 years
Disqualifiers
Non-idiopathic scoliosis (i.e. neuromuscular, syndromic or congenital scoliosis)
Previous spine surgery
Trial design
Parallel
Treatments tested in this trial
3D TLSO
DeviceBrace treatment with Boston 3D 20 hours a day until skeletal maturity.
Standard TLSO
DeviceBrace treatment with standard Boston brace 20 hours a day until skeletal maturity.
Treatment groups
Trial outcomes
Primary outcomes
Curve progression
Increase in curve severity (Cobb angle) of more than 6 degrees on two consecutive radiographs after baseline
Secondary outcomes
Clinical outcomes
Angle of trunk rotation in forward bending, assessed with scoliometer
Patient-reported outcome measures
Scoliosis Research Society-22r questionnaire
Patient-reported outcome measures
EQ5D questionnaire
Patient-reported outcome measures
Spinal Appearance Questionnaire (SAQ)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Karolinska Institutet
Lead sponsor
Linkoeping University
Collaborator